Siddiqui Ali, Naveed Mariam, Basha Jahangeer, Lakhtakia Sundeep, Nieto Jose, Shah Janak, Binmoeller Kenneth, Murphy Megan, Talukdar Rupjyoti, Ramchandani Mohan K, Nabi Zaheer, Gupta Rajesh, Kowalski Thomas E, Loren David E, Sharaiha Reem Z, Kahaleh Michel, Eyck Patrick Ten, Noor Arish, Mumtaz Tayebah, Kalalala Rakesh, Reddy Nageshwar D, Adler Douglas G
Thomas Jefferson University, Philadelphia, PA, USA (Ali Siddiqui, Megan Murphy, David E. Loren, Arish Noor, Tayeban Mumtaz).
University of Iowa, Iowa City, IA, USA (Mariam Naveed, Patrick Ten Eyck).
Ann Gastroenterol. 2021;34(2):273-281. doi: 10.20524/aog.2021.0570. Epub 2021 Jan 4.
To compare fully covered bi-flanged metal stents (BFMS) and lumen-apposing metal stents (LAMS) for endoscopic ultrasound (EUS)-guided drainage/debridement of pancreatic walled-off necrosis (WON).
Patients with WON managed by EUS-guided therapy were divided into those who underwent: 1) drainage using BFMS; and 2) drainage using LAMS and scheduled direct endoscopic necrosectomy (DEN). Clinical success (resolution of the WON), technical success (successful stent placement), and adverse events (AEs) were evaluated.
387 patients underwent WON endoscopic drainage, 205 using BFMS and 182 using LAMS. The clinical success in the BFMS or LAMS groups were similar (197 [96.1%] vs. 174 [95.6%]; P=0.81). Median number of procedures required for WON resolution was significantly lower in BFMS compared to LAMS (2 vs. 3, P<0.001). Technical success for stent placement was similar in BFMS and LAMS groups (203 [99%] vs. 180 [99%], P=0.90). Procedure-related AEs were similar in the BFMS and LAMS groups (19 [9.3%] vs. 20 [10.9%], P=0.61). Stent dysfunction with occluding debris was higher in the BFMS group compared to LAMS group (21 [10.2 %] vs. 11 [5.9%], P=0.04). The migration rate was higher in the BFMS group than in the LAMS group (15 [7.3%] vs. 3 [1.6%]; P<0.001). DEN was required in 23 [11.2%] patients in the BFMS group after lack of WON resolution by conservative means.
BFMS with a "step-up approach" and LAMS with scheduled DEN are both safe and effective for EUS-guided drainage/debridement of WON.
比较全覆膜双凸缘金属支架(BFMS)和管腔贴壁金属支架(LAMS)用于内镜超声(EUS)引导下胰腺壁内坏死(WON)的引流/清创。
接受EUS引导治疗的WON患者被分为两组:1)使用BFMS进行引流;2)使用LAMS进行引流并计划进行直接内镜坏死组织切除术(DEN)。评估临床成功率(WON的消退)、技术成功率(支架成功置入)和不良事件(AE)。
387例患者接受了WON内镜引流,205例使用BFMS,182例使用LAMS。BFMS组和LAMS组的临床成功率相似(197例[96.1%]对174例[95.6%];P = 0.81)。与LAMS相比,BFMS使WON消退所需的手术中位数显著更低(2次对3次,P < 0.001)。BFMS组和LAMS组支架置入的技术成功率相似(203例[99%]对180例[99%],P = 0.90)。BFMS组和LAMS组与手术相关的AE相似(19例[9.3%]对20例[10.9%],P = 0.61)。BFMS组因堵塞碎片导致的支架功能障碍高于LAMS组(21例[10.2%]对11例[5.9%],P = 0.04)。BFMS组的迁移率高于LAMS组(15例[7.3%]对3例[1.6%];P < 0.001)。BFMS组中23例(11.2%)患者在保守治疗未能使WON消退后需要进行DEN。
采用“逐步升级方法”的BFMS和计划进行DEN的LAMS在EUS引导下对WON进行引流/清创均安全有效。